All Stories

  1. Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis Treatment
  2. Polyvinyl Alcohol Cryogels for Acoustic Characterization of Phase-Change Contrast Agents
  3. Applications of sub-micron low-boiling point phase change contrast agents for ultrasound imaging and therapy
  4. Harnessing ultrasound-stimulated phase change contrast agents to improve antibiotic efficacy against methicillin-resistant Staphylococcus aureus biofilms
  5. Feasibility of an Inhalable Ultrasound Contrast Agent to Enhance Airway Imaging
  6. Magnetic Resonance Detection of Gas Microbubbles via HyperCEST: A Path Toward Dual Modality Contrast Agent
  7. Acoustic holograms for directing arbitrary cavitation patterns
  8. Harnessing Ultrasound-Stimulated Phase Change Contrast Agents to Improve Antibiotic Efficacy Against Methicillin-Resistant Staphylococcus aureus Biofilms
  9. A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis Therapy
  10. Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis
  11. Inorganic nanoparticles and the microbiome
  12. Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
  13. A dry powder combination of pyrazinoic acid and its n-propyl ester for aerosol administration to animals
  14. Inhaled drug treatment for tuberculosis: Past progress and future prospects
  15. Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis
  16. Correction for Spray Dried Aerosol Particles of Pyrazinoic Acid Salts for Tuberculosis Therapy
  17. Spray Dried Aerosol Particles of Pyrazinoic Acid Salts for Tuberculosis Therapy
  18. Controlled degradation of disulfide-based epoxy thermosets for extreme environments
  19. Particle uptake efficiency is significantly affected by type of capping agent and cell line
  20. In vitro dry powder inhaler formulation performance considerations
  21. The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy
  22. Abstracts: International Society for Aerosols in Medicine 19th International Congress Chapel Hill, North Carolina, USA April 6–10, 2013